Velvet Rx Review

Best for: cash-pay patients comfortable with a compounded-GLP-1 telehealth model who prioritize three publicly-listed SKUs and bundled shipping over LegitScript / NABP certification, named pharmacy partner, or per-state availability verification

Velvet Rx (velvetrx.com) is a cash-pay telehealth platform offering compounded semaglutide, compounded tirzepatide, and an oral GLP-1 across three publicly-listed SKUs ranging from $139 to $199 'today' (first-month promo) with regular monthly prices of $299 / $359 / $349. Plans bundle a doctor consult, written prescription, 4 weeks of medication, free 1-2 day shipping, and 24/7 medical team access. Cash only; FSA/HSA eligible.

By Eli Marsden · Founding Editor
Editorially reviewed (not clinically reviewed) · How we verify contentLast reviewed

Medium confidence · Last verified 2026-05-10 via manual · How we verify provider data

6.6
★★★☆☆3.3
CompoundedSemaglutideTirzepatideOral GLP-1Cash-Pay (No Insurance)FSA / HSA Eligible24/7 Medical Team Access (provider claim)Free 1-2 Day Shipping (provider claim)

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

The Bottom Line

Velvet Rx is a solid telehealth option with balanced features and pricing.

Score: 6.6/10Best for: cash-pay patients comfortable with a compounded-GLP-1 telehealth model who prioritize three publicly-listed SKUs and bundled shipping over LegitScript / NABP certification, named pharmacy partner, or per-state availability verificationFrom: $139/mo

Score Breakdown

Value
7
Effectiveness
6.5
User Experience
6.5
Trust & Safety
5.5
Accessibility
7
Support
7

Drugs Offered

Velvet Rx prescribes the following GLP-1 medications. Tap a drug to read our clinical guide with FDA label info, dosing schedules, side effects, and trial data.

Pricing

DoseFormPrice/mo
Compounded semaglutide injection (first month promo)compounded$139
Compounded semaglutide injection (regular monthly)compounded$299
Compounded tirzepatide injection (first month promo)compounded$199
Compounded tirzepatide injection (regular monthly)compounded$359
Oral GLP-1 (specific drug not named) (first month promo)compounded$189
Oral GLP-1 (specific drug not named) (regular monthly)compounded$349

Pros

  • Publicly-disclosed pricing across 3 SKUs (semaglutide injection $299, tirzepatide injection $359, Oral GLP-1 $349) — uncommon transparency in the compounded telehealth segment
  • First-month promo pricing displayed verbatim on home: $139 sema / $199 tirz / $189 oral
  • Doctor consult, prescription, 4 weeks of medication, AND free 1-2 day shipping all included in single monthly price (verbatim: 'Same price, every dose. No hidden fees')
  • FSA / HSA eligibility claimed verbatim on the home
  • Three modalities under one roof: injectable sema, injectable tirz, and an oral GLP-1 option
  • No insurance accepted — fully cash-pay model with no membership fee disclosed

Cons

  • Oral GLP-1 SKU does NOT name the specific drug (Rybelsus? Foundayo? compounded oral semaglutide? — not disclosed) — material transparency gap given the three are clinically distinct (Rybelsus is T2D-indicated only, Foundayo is FDA-approved for chronic weight management, compounded oral has unsettled regulatory status)
  • No LegitScript Certified or NABP .pharmacy seal displayed on home or footer
  • No legal entity name disclosed publicly (footer reads only 'Copyright © 2025 VelvetRx')
  • No physical address disclosed publicly
  • No partner pharmacy named — does NOT disclose which 503A or 503B compounding pharmacy fills prescriptions
  • States available NOT enumerated — no state-by-state availability disclosure
  • Pricing display has internal inconsistency: hero shows '$299 $139 today' for sema; pricing card adds 'Save $60 instantly on your first month, then $100 off each month' which would imply $239 first / $199 ongoing — different math than the headline $139
  • Marketing claims include unverifiable percentages ('92% of patients are on track by month one,' '15% average body weight loss in first 90 days,' '9/10 patients say it's the most effective treatment they've ever tried') with no cited methodology, sample size, or independent audit
  • No FDA warning letters found for 'Velvet Rx' or 'VelvetRx' in the FDA warning-letter database as of 2026-05-10 — but this absence is not affirmative evidence of pharmacy quality

Ready to start with Velvet Rx?

Starting at $139/month. See current pricing and start your free consultation.

Sources & methodology

Our Velvet Rx review applies the same 6-dimension scoring framework we use for every provider. Pricing, FDA approval status, compounding rules, and clinical-trial efficacy claims are sourced from the primary regulatory and peer-reviewed literature below.

Sources & methodology — as of May 2026
  1. 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)WeightLossRankings.org.
  2. 2.FDA — Compounding and the 503A Pharmacy FrameworkU.S. Food & Drug Administration.
  3. 3.FDA — Drug Shortages Database (current shortage listings)U.S. Food & Drug Administration.
  4. 4.PCAB — Pharmacy Compounding Accreditation Board StandardsAccreditation Commission for Health Care (ACHC) / PCAB.
  5. 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)Kaiser Family Foundation.
  6. 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)New England Journal of Medicine.PMID: 33567185.
  7. 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDAU.S. Food & Drug Administration.
  8. 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDAU.S. Food & Drug Administration.
  9. 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)New England Journal of Medicine.PMID: 35658024.
  10. 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDAU.S. Food & Drug Administration.
  11. 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDAU.S. Food & Drug Administration.
  12. 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)New England Journal of Medicine.PMID: 40334173.

Alternatives to Velvet Rx

7.0/ 10

Actin

Best for: affordable compounded semaglutide with B12 enhancement

★★★3.5

Editorial score · methodology

$133/mo
CompoundedSemaglutide
Get StartedRead full Actin review →
7.1/ 10

AgelessRx

Best for: longevity-focused GLP-1 care (pending verification)

★★★3.6

Editorial score · methodology

$199/mo
CompoundedSemaglutide
Get StartedRead full AgelessRx review →
7.7/ 10

Alan Meds

Best for: budget-conscious shoppers

★★★3.9

Editorial score · methodology

$99/mo
CompoundedSemaglutideTirzepatide
Get StartedRead full Alan Meds review →

Frequently Asked Questions

Glossary references

Key terms in this article, linked to their canonical definitions.

Ready to start with Velvet Rx?

Starting at $139/month. See current pricing and start your free consultation.